SCANDION ONCOLOGY A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.355 SEK | +0.37% |
|
0.00% | -66.08% |
| 05-15 | Transcript : Scandion Oncology A/S - Special Call | |
| 03-21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
Chart calendar Scandion Oncology A/S
1.oOPFUzNCORFrf4Z1N-mTy6uZFVa1OnutJZ2cWrNsJgg.-ZqcEkM4cVI0M8UHZYK-r-H1ej6HfgmAHfLRMeMkU27E0KAFcQBRfyUZ9Q~8e268c282d4389d67c16508ca689767a
Upcoming events on Scandion Oncology A/S
Past events on Scandion Oncology A/S
| 2024-05-06 08:00 | Annual General Meeting |
| 2024-02-28 04:00 | Q4 2023 Earnings Call |
| 2024-02-28 03:00 | Q4 2023 Earnings Release |
| 2024-02-05 08:00 | R&D Day |
| 2023-11-22 04:00 | Q3 2023 Earnings Call |
| 2023-11-21 | Q3 2023 Earnings Release |
| 2023-10-19 | European Society for Medical Oncology Congress |
| 2023-10-09 | LSX Nordic Congress |
| 2023-08-25 02:30 | Q2 2023 Earnings Release |
| 2023-08-23 04:00 | Q2 2023 Earnings Call |
| 2023-05-26 04:00 | Q1 2023 Earnings Call |
| 2023-05-26 03:00 | Q1 2023 Earnings Release |
| 2023-04-25 | Annual General Meeting |
| 2023-02-22 04:00 | FY 2022 Earnings Call |
| 2023-02-21 | FY 2022 Earnings Release Pre-market |
| 2022-11-16 04:00 | Q3 2022 Earnings Call |
| 2022-11-16 02:30 | Q3 2022 Earnings Release |
| 2022-10-28 05:00 | Extraordinary Shareholders Meeting |
| 2022-08-25 04:00 | Interim 2022 Earnings Call |
| 2022-08-24 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,30 - | 0,00 0,00 - |
|
EBITDA Million DKK | Released Forecast Spread | 0,00 | -54,9 -54,0 -1.7% | -79,3 -85,5 7.3% | -44,4 -41,0 -8.26% |
|
EBIT Million DKK | Released Forecast Spread | 0,00 | -55,0 -54,0 -1.82% | -80,2 -86,0 6.73% | -45,4 -41,0 -10.63% |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 0,00 | -56,8 -54,0 -5.23% | -82,2 -86,8 5.34% | -44,7 -41,0 -9.03% |
|
Net income Million DKK | Released Forecast Spread | -16,3 | -51,3 -42,0 -22.18% | -76,7 -81,1 5.41% | -39,2 -35,0 -12.01% |
|
EPS SEK | Released Forecast Spread | -1,13 | -2,28 -1,80 -26.6% | -2,78 -3,14 11.69% | -1,44 -0,31 -370.07% |
| Announcement Date | 29/04/21 | 17/02/22 | 22/02/23 | 28/02/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 |
|---|---|---|
|
Net income Million DKK | Released Forecast Spread | -12,9 |
|
EPS SEK | Released Forecast Spread | -0,56 |
| Announcement Date | 19/05/22 |
More events
Past sector events for Scandion Oncology A/S
| Today 09:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| Today | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:00 | IMMATICS N.V.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-14 01:00 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCOL Stock
- Calendar Scandion Oncology A/S